Ultimovacs ASA ULTI.OL Stock
9.97 NOK
{{ price }}
2.783510%
{{change_pct}}%
SECTOR
Healthcare
INDUSTRY
Biotechnology
COUNTRY
Norway
Exchange
Oslo
Market Cap
343.03M NOK
LOW - HIGH [24H]
9.53
-
10.02 NOK
VOLUME [24H]
686.37K NOK
{{ volume }}
P/E Ratio
0
Earnings per share
-5.5 NOK
Ultimovacs ASA Price Chart
Ultimovacs ASA ULTI.OL Financial and Trading Overview
| Ultimovacs ASA stock price | 9.97 NOK |
| Previous Close | 77.3 NOK |
| Open | 78 NOK |
| Bid | 77.6 NOK x N/A |
| Ask | 78.1 NOK x N/A |
| Day's Range | 77 - 78 NOK |
| 52 Week Range | 58.5 - 142.6 NOK |
| Volume | 30.73K NOK |
| Avg. Volume | 57.47K NOK |
| Market Cap | 2.69B NOK |
| Beta (5Y Monthly) | 1.432658 |
| PE Ratio (TTM) | N/A |
| EPS (TTM) | -5.5 NOK |
| Forward Dividend & Yield | N/A (N/A) |
| Ex-Dividend Date | N/A |
| 1y Target Est | 164.5 NOK |
ULTI.OL Valuation Measures
| Enterprise Value | 2.26B NOK |
| Trailing P/E | N/A |
| Forward P/E | 10.209424 |
| PEG Ratio (5 yr expected) | N/A |
| Price/Sales (ttm) | N/A |
| Price/Book (mrq) | 6.3404326 |
| Enterprise Value/Revenue | N/A |
| Enterprise Value/EBITDA | -11.462 |
Trading Information
Ultimovacs ASA Stock Price History
| Beta (5Y Monthly) | 1.432658 |
| 52-Week Change | 18.37% |
| S&P500 52-Week Change | 20.43% |
| 52 Week High | 142.6 NOK |
| 52 Week Low | 58.5 NOK |
| 50-Day Moving Average | 118.99 NOK |
| 200-Day Moving Average | 102.39 NOK |
ULTI.OL Share Statistics
| Avg. Volume (3 month) | 57.47K NOK |
| Avg. Daily Volume (10-Days) | 153.06K NOK |
| Shares Outstanding | 34.4M |
| Float | 18.65M |
| Short Ratio | N/A |
| % Held by Insiders | 48.41% |
| % Held by Institutions | 24.87% |
| Shares Short | N/A |
| Short % of Float | N/A |
| Short % of Shares Outstanding | N/A |
Dividends & Splits
| Trailing Annual Dividend Rate | 0 |
| Trailing Annual Dividend Yield | 0% |
| 5 Year Average Dividend Yield | N/A |
| Payout Ratio | 0 |
| Last Split Factor |
Financial Highlights
Fiscal Year
| Fiscal Year Ends | December 31, 2022 |
| Most Recent Quarter (mrq) | March 31, 2023 |
| Next Fiscal Year End | December 31, 2023 |
Profitability
| Profit Margin | 0% |
| Operating Margin (ttm) | 0% |
| Gross Margin | 0% |
| EBITDA Margin | 0% |
Management Effectiveness
| Return on Assets (ttm) | -22.56% |
| Return on Equity (ttm) | -33.74% |
Income Statement
| Revenue (ttm) | N/A |
| Revenue Per Share (ttm) | N/A |
| Quarterly Revenue Growth (yoy) | N/A |
| Gross Profit (ttm) | N/A |
| EBITDA | -196980992 NOK |
| Net Income Avi to Common (ttm) | -165303008 NOK |
| Diluted EPS (ttm) | -4.72 |
| Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
| Total Cash (mrq) | 406.13M NOK |
| Total Cash Per Share (mrq) | 11.81 NOK |
| Total Debt (mrq) | 5.05M NOK |
| Total Debt/Equity (mrq) | 1.19 NOK |
| Current Ratio (mrq) | 7.273 |
| Book Value Per Share (mrq) | 12.302 |
Cash Flow Statement
| Operating Cash Flow (ttm) | -159114000 NOK |
| Levered Free Cash Flow (ttm) | -79651624 NOK |
Profile of Ultimovacs ASA
| Country | Norway |
| State | N/A |
| City | Oslo |
| Address | Ullernchausséen 64 |
| ZIP | 0379 |
| Phone | 47 41 38 00 80 |
| Website | https://ultimovacs.com |
| Industry | Biotechnology |
| Sector(s) | Healthcare |
| Full Time Employees | 24 |
Ultimovacs ASA, a biotech company, develops immunotherapies against cancers. Its lead product candidate is UV1, a peptide-based cancer vaccine that induces a specific T cell response against the universal cancer antigen telomerase. The company was incorporated in 2011 and is headquartered in Oslo, Norway.
Q&A For Ultimovacs ASA Stock
What is a current ULTI.OL stock price?
Ultimovacs ASA ULTI.OL stock price today per share is 9.97 NOK.
How to purchase Ultimovacs ASA stock?
You can buy ULTI.OL shares on the Oslo exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for Ultimovacs ASA?
The stock symbol or ticker of Ultimovacs ASA is ULTI.OL.
Which industry does the Ultimovacs ASA company belong to?
The Ultimovacs ASA industry is Biotechnology.
How many shares does Ultimovacs ASA have in circulation?
The max supply of Ultimovacs ASA shares is 34.41M.
What is Ultimovacs ASA Price to Earnings Ratio (PE Ratio)?
Ultimovacs ASA PE Ratio is now.
What was Ultimovacs ASA earnings per share over the trailing 12 months (TTM)?
Ultimovacs ASA EPS is -5.5 NOK over the trailing 12 months.
Which sector does the Ultimovacs ASA company belong to?
The Ultimovacs ASA sector is Healthcare.
Ultimovacs ASA ULTI.OL included in indexes
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume |
|---|
| Name Name | Price Price |
24h% 7d chart 24h% & 7d |
VOL Volume | 24h low | 24h high | Volume | |
|---|---|---|---|---|---|---|---|
| {{ item.name }} {{ item.symbol }} | {{ item.price }} {{ item.price_usd }} |
{{ item.change_pct }}
|
{{ item.volume }} {{ item.volume_usd }} | {{ item.low }} {{ item.low_usd }} | {{ item.high }} {{ item.high_usd }} | {{ item.components_count }} - | {{ item.volume }} {{ item.volume_usd }} |
| Oslo Bors All-Share Index_GI OSEAX | 1017.37 NOK 97.59 USD |
+1.04
|
371.46M NOK 35.63M USD | 1003.3 NOK 96.24 USD | 1018.4 NOK 97.69 USD | — - | 371.46M NOK 35.63M USD |
- {{ link.label }} {{link}}